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Abstract 
Background: To study the morphological types of 
ovarian tumours .  
Methods: In this  descriptive, cross sectional study 
all consecutive specimens of ovarian tumours . Gross 
examination was done, representative sections taken, 
processed and paraffin embedded blocks made. 
Sections of blocks were taken by microtome and the 
prepared slides were stained by H&E stain and 
examined under the microscope. Results obtained 
were analyzed according to age and tumour type. 
 
Results: A total of 182 cases of ovarian neoplastic 
lesions were reported, out of which 67.6% were 
benign while 32.4% were malignant tumours. 
Surface epithelial tumours were the commonest and 
constituted 49.2 % followed by germ cell tumours 
20.3 %, sex cord stromal tumours 18.6 % and 
metastatic tumours 11.9 %. Mucinous tumours were 
more common than serous tumours. Among the 
benign category, mature cystic teratoma was the 
commonest.Benign tumours were more common in 
young females while incidence of malignant 
tumours increased with the advancing age.   
Conclusion: Benign ovarian tumours are more 
common than malignant ovarian tumours. Among 
the surface epithelial tumours, mucinous tumours 
are the commonest in our study followed by germ 
cell tumours. Recognition of border line tumours is 
very important because such patients need close 
follow up. 
Key  Words: Ovarian tumours ,Surface epithelial 
tumour, Teratoma 
Introduction 
Ovarian tumours pose a major cause of morbidity and 
mortality in gynecological patients.1 They are usually 
asymptomatic and present late due to pressure 
symptoms caused by their large size.2They may be 
diagnosed incidentally on ultrasound examination 
done for another cause.  Patients usually have 
nonspecific symptoms and complain of abdominal or 
pelvic discomfort, pain, fatigue, urinary frequency and 
increased abdominal girth3, 4 
According to studies, incidence of ovarian tumours 
varies globally. It is more common in European and 
American countries than Asia. In United Kingdom it is 
the fifth most common cancer and is the leading cause 
of death from gynecological cancer.5They are reported 
to be the 4th most common malignancy in the women 
of eastern India and Pakistan, 4thmost common 
malignancy in Lahore city and 10.2 per 100,000 per 
year in Karachicity.4,6  According to WHO 
classification, ovarian tumours can be either surface 
epithelial tumours, sex cord stromal tumours, germ 
cell tumours or metastatic tumours. Fortunately, most 
of these tumours are benign.  
Benign tumours mostly occur in child bearing age 
while malignant tumours occur in the elderly females 
and Incidence increases with the increasing age7. 
Ovarian tumours are rare in children constituting 1 % 
of all childhood malignancies. Germ cell tumours 
usually present in teen agers and young women. If 
diagnosed in time, approximately 90 % of germ cell 
tumours can be cured while preserving fertility8.Exact 
cause of ovarian tumours is not clear. Main risk factors 
are reproductive age, long term estrogen intake as 
replacement therapy and positive family history of 
cancers of other than that of ovaries, especially 
breast.9,10Tubal ligation, hysterectomy at early age, 
high parity and healthy life style have been reported to 
have protective effects. 11- 13 Prognosis of tumours is 
predicted by the early detection, degree of 
differentiation, stage and laterality.14 
 
Patients and Methods  
It was a descriptive cross sectional study done in the 
department of histopathology, Holy Family Hospital, 
Rawalpindi from 1st January 2013 to 31st December 
2015.All the specimens of ovarian tumours received in 
the department of Histopathology were included in 
the study. Gross examination of the specimen was 
done, representative sections taken and processed in 
an automatic tissue processor. Paraffin blocks were 
prepared and 3 -5 micron thick sections were taken by 
the microtome. Prepared slides were stained by H& E 
stain and examined under the microscope. Results 
obtained were analyzed according to age and tumour 
type.Unfixed and autolyzed specimens were not 
included in the study. 
Results 
During the study period, a total of 491 consecutive 
cases of ovarian specimens were received.  Three 
hundred and nine (62.9 %) ovaries were having non 
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neoplastic lesions while 182 (37.1 %) cases were 
diagnosed as neoplasms.(Table - I). 
Table  1:Distribution of total benign, borderline 













69(56.1) 9(9.18) 20(40) 98(53.84) 
Germ Cell  
Tumours 




6(4.9) - 11(22) 17(9.34) 
Metastatic 
Tumoursa 
- - 7(14) 7(3.85) 
Total 123(67.6) 9(4.95) 50(27.5) 182(100) 
Table  2: Age Distribution of 182 benign, 
borderline and malignant ovarian tumours. 
Age 
(years) 
Benign Border line Malignant  
10-19 5  6 
20-29 47 4 6 
30-39 35 1 12 
40-49 18 1 9 
50-59 12 3 13 
60-69 5  4 
70 or > 1   
Table 3 : Distribution of  ovarian neoplastic 
lesions according to age 
Age 
(years) 












10-19 3  8  
20-29 26 4 25 2 
30-39 33 4 25 2 
40-49 17 3 6 2 
50-59 16 6 4 2 
60-69 3 2 4  
70 or >    1 
Table  4: Distribution of benign lesions (n=123) 
Microscopic type of benign  tumors Number %  
 Epithelial Tumoors 69 56.1 
Serous Tumors 34 27.64 
Serous cyst adenoma  29 23.57 
Serous cyst adenofibroma 5 4.o6 
Mucinous Tumors 35 28.45 
Germ Cell Tumours 48 39 
Mature cystic Teratoma 47 39 
Monodermal teratoma with Stroma ovarrii 1  0.81 
Sex Cord & Stromal Tumours 6 4.9 
Thecoma 1 0.81 
Fibroma 2 1.63 
Fibrothecoma 3 2.44 
 
Table  5: Distribution of 50 malignant and 9 
borderline tumors lesions (n=50) 
Microscopic type of malignant 
tumour 
Number of  
cases 
% 
Epithelial Tumours 20 + 9●  40 + 4.95 
Serous Tumours 9 31* 
serous borderline tumour 3 1.6● ● ●  
serous adenocarcinoma 6 12 
Mucinous Tumours 13 44.8* 
mucinous borderline tumour 6 3.3● ● ●  
mucinous adenocarcinoma 7 14 
Endometrioid adeno carcinoma 3 6 
Malignant Brenner Tumour 3 6 
Poorly differentiated 
carcinoma 1 2 
Germ Cell Tumours 12 24 
Immature Teratoma 4 8 
Dysgerminoma 3 6 
Yolk sac Tumour 1 2 
Malignant mixed Germ cell 
Tumor 3 6 
Embryonal carcinoma 1 2 
Sex Cord & Stromal Tumours 11 22 
Granulosa cell tumours 11 22 
Metastatic Tumours 7 14 
Total 50 +9 100+ 4.9  
● Borderline tumor, ●●,●●● - % of 182 total neoplastic 
tumors;* % of total malignant and borderline epithelial 
tumour 
 
Majority were seen in age group 20-29 (Table 2). 
Among benign neoplasms, surface epithelial tumours 
were the commonest(56.1%)  followed by germ cell 
tumours (39%) and  sex cord stromal tumours( 4.9 %) 
(Table-3).In benign tumours epithelial tumours were 
commnest (Table 4)Mucinous cyst adenoma was the 
commonest benign surface epithelial tumor-n= 35 
(28.45 %) followed by serous cystadenoma –n=29 
(23.57 %). benign germ cell tumour (Mature cystic 
teratoma) -n=47 (39 %). Fibrothecoma was the 
commonest benign sex cord stromal tumours –n=3 
(2.44 %) (Table -2).Age range for benign tumours was 
17 to 70 years with mean of 33.8. Maximum cases were 
in the age group of 20 to 29 years – n=47 (38.2 %) (Fig – 
1). 
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Figure 1: Gross specimen of Mucinous 
cystadenocarcinoma. Cut surface is gelatinous, cystic and 
solid with hemorrhagic areas 
 
Figure  2 - Mucinous cystadenoma showing lining of tall 
columnar epithelium of endocervical type with papillary 
growths.  
 
Figure 3:- Mucinous borderline tumor.; Inset shows  
nuclear pleomorphism 
 
Figure 4: Mucinous cystadenocarcinoma showing stromal 
destruction;inset shows nuclear pleomorphism and 
necrosis . 
 
Figure 5: Serous cystadenoma ; Inset shows serous lining 
epithelium.   
 
Figure 6: Papillary Serous cystadenocarcinoma; Inset 
shows complex papillae formation 
 
Figure 7: Endometrioid carcinoma; Inset shows 
villoglandular pattern 
 
Figure 8: Dysgerminoma; Inset shows nests of tumour cell 
separated by scanty fibrous stroma and infiltration of 
lymphocytes. Cells have well-defined cell borders. 
 
Figure  9:Yolk sac tumor; Inset shows Schiller 
 Duval body 
 
Figure 10: Mature cystic teratoma showing heterogeneous 
tissue 
 
Figure 11: Immature teratoma ; Inset shows immature 
neuroepithelium 
 
Figure 12:Photomicrographs of granulosa cell tumour  
(sexcord stromal tumour) 
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Commonest tumour in this age group was mature 
cystic teratoma 47.9% (Fig – 3).Among the borderline 
tumours, 6 (3.3 % of total 182 tumours) were 
borderline mucinous tumour while 3 (1.6 %) were 
serous borderline tumours (Table 5). Surface epithelial 
tumours were the commonest among the malignant 
neoplasms- n= 20 (40%), followed by germ cell 
tumours- n= 12 (24%), Sex cord stromal tumours n-11 
(22%) and metastatic tumours – 7 (14%) (Table , Figure 
 4).Among the malignant surface epithelial tumours, 
mucinous tumours were the commonest -n=7 (14%) 
followed by serous tumours –n= 6 (12%).Other surface 
epithelial tumours which were diagnosed in the study 
included, endometrioid adenocarcinoma and 
malignant brenner tumour, 6 % each. One case (2 %) of 
poorly differentiated carcinoma was also found. Germ 
cell tumours were the second most common malignant 
tumour. Immature teratoma was the commonest-n= 4 
(6.8%), followed by dysgerminoma and malignant 
mixed germ cell tumours constituting 3 (6 %) each 
(Figure 1-12). Yolk sac tumour and embryonal 
carcinoma , each constituting 1( 1.7%) were also found. 
Among the sex cord stromal tumours, 11 cases of 
Granulosa cell tumour constituting 11 (22 %)were 
identified. Frequency of metastatic tumours was 14 % 
(n= 7). (Table 3).Age range for malignant tumours was 
13 years to 69 years with the mean age of 39.0. 
Maximum cases were between 50 to 59 years – n= 16 
(27.1%) (Fig: 1 and 4). 
Discussion 
Although most ovarian lesions are non-neoplastic, the 
neoplastic lesions are also fairly common. Benign 
tumours are more common than the malignant 
tumours. They usually present late, either after the 
tumour attains a huge size and produces pressure 
effects, or when the complications start. In our study 
size of ovarian tumours measured was up to 23 cm in 
greatest dimension.  
In the present study age range of patients was 13 to70 
years with mean of 35.5 years. It is comparable with 
the studies conducted in Pakistan.1, 15Mean age of 
patients in these studies was 38.82 +8.51 and 35.6 years 
respectively. For benign tumours, in our study was 17 
to 70 years with mean age of 33.77 and for malignant 
tumours it was 13 to 69 years with mean age of 39.03.  
Most of the benign tumours in our study were found 
in 3rd and 4th decades of life while most of malignant 
tumors were seen in 5th and 6th decades. These results 
are comparable with the studies done by other 
workers in Pakistan who have also found that benign 
tumours occur in younger age group while malignant 
tumours were mostly found in old age. 16, 17, 18, 22 
In our study, benign tumours (67.6 %) were more 
common than the malignant tumours(27.5 %.). This 
finding was also observed by Sheikh etal  Ahmed et al. 
and Ashraf et al  who reported benign tumours as 
68.28%, 65.35% and 64.57 % and malignant tumours as 
31%, 30.1 % and 35.43 % respectively.2,15,17 In contrast 
to our findings, Yasmin et al, Bukhari et al and 
Rahman documented relatively higher frequency of 
benign tumours than our study constituting (80 to 
89%) and low incidence of malignant tumours (10.2 to 
24 %). 1,16,18 Our study is comparable to the findings of 
studies done in India (36.5%)  and Nepal (31%) , which 
also documented high incidence of malignant 
tumours.19,20 The reason for this relatively high 
frequency of malignant tumours in our setup might be 
as this is a tertiary care hospital and we also receive 
referral cases from other hospitals. Surface epithelial 
tumours were most common among all the neoplastic 
tumours (56.1%) followed by germ cell tumours (39%). 
These results are in agreement with the findings of 
other studies.2, 17,18,21 Tumours of border line category 
are tumours having atypical epithelial proliferation 
with nuclear abnormalities and mitotic activity 
without stromal invasion. These tumours are 
considered as intermediate tumour between benign 
and malignant tumours of similar type. They are also 
called tumours of low malignant potential. In our 
study we found 9 (4.95 %) border line tumours. 3.3 % 
were mucinous border line tumours and 1.6 % were 
serous border line tumours. This finding is in 
agreement with other studies done in Pakistan.21,22 
Among the malignant tumours in our study, mucinous 
and serous carcinomas are most common tumours. 
This finding is in agreement with other studies.15, 17, 18, 
21 Yasmin et al observed the endometrioid carcinoma 
as the commonest epithelial malignancy (28.5%). 1 
In our study mucinous tumours were more common 
as compared to serous tumours both in benign( 28.45 
vs 27.64 %) and malignant (11.9% vs 10.16 %) 
epithelial tumour category. it is comparable with local 
studies.23,24 However it  in not in agreement with 
different studies in which frequency of serous tumours 
was reported to be more common than mucinous 
tumors.615, 16, 21,22 This difference may be due to 
variation in sample size and other environmental 
factors.21Frequency of germ cell tumour was second to 
epithelial tumours in our study 60 (33 %). Benign 
tumours (mature cystic teratoma) 48 (39 %) were more 
common than malignant germ cell tumours 
12(24%).This is comparable with the study done by 
Ahmed et al 2000, and in studies done in Malays and 
Chinese.22,25 
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Frequency of sex cord stromal tumours in the current 
study was 9.34%  which is in agreement with the 
studies done by Tanwani (10.1%) and Abdullah and 
Bondagji (7.6 %).21,26 However it is higher than 
reported by Ahmed et al , Ashraf et al  and Rahman et 
al ( 3.15 to 4.46%). 15,17,18 Commonest benign tumour 
was fibrothecoma while most common malignant 
tumour was granulosa cell tumour. This is comparable 
with the results of Ashraf et al. 15Metastatic tumours 
constituted 3.85 % in our study. The results are 
comparable with other studies 15, 21.  
Conclusion 
1.Incidence of benign tumors is more common in 
young females while frequency of malignant tumors 
increases with the advancing age.  
2Mucinous tumors are more common than the serous 
tumors.  
3.Close followup is necessary for border line cases in 
these patients to improve the survival 
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